| Net income (loss) | -22.7M |
| Depreciation and amortization | 34.2M |
| Deferred income taxes | -11M |
| Provision for allowances, claims and doubtful accounts | 1.2M |
| Impairment charges on fixed assets and goodwill | 0 |
| Gain on sale of assets | -1.3M |
| Restructuring and other charges | 0 |
| Loss on retirement of debt | 11.2M |
| Other items | 400K |
| Receivables | -85.8M |
| Inventories | -5.8M |
| Other assets | 6.2M |
| Accounts payable | 57.7M |
| Accrued liabilities | 28.4M |
| Accrued taxes payable/receivable | 1.3M |
| Deferred employee benefit costs | -58.6M |
| Net adjustments | -21.9M |
| Net cash provided by (used in) operating activities | -44.6M |
| Increase in restricted cash | -100K |
| Capital expenditures | -13.7M |
| Proceeds from sales of property, plant and equipment | 3.9M |
| Net cash provided by (used in) investing activities | -9.9M |
| Capital contribution from Ryerson Holding | 110.7M |
| Repayment of debt | -110.7M |
| Net proceeds/(repayments) of short-term borrowings | 32.5M |
| Long-term debt issuance costs | 0 |
| Credit facility issuance costs | 0 |
| Net increase in book overdrafts | 21.8M |
| Principal payments on capital lease obligation | -700K |
| Net cash provided by (used in) financing activities | 53.6M |
| Net increase (decrease) in cash and cash equivalents | -900K |
| Effect of exchange rate changes on cash and cash equivalents | -4.5M |
| Net change in cash and cash equivalents | -5.4M |
| Cash and cash equivalents-beginning of period | 74M |
| Cash and cash equivalents-end of period | 68.6M |
| Interest paid to third parties | 58.5M |
| Income taxes, net | 800K |
| Asset additions under capital leases | 3.5M |